<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00496964</url>
  </required_header>
  <id_info>
    <org_study_id>PT_PMR_3700</org_study_id>
    <nct_id>NCT00496964</nct_id>
  </id_info>
  <brief_title>Botox for Non-surgical Lateral Release in Patellofemoral Pain</brief_title>
  <official_title>Botox for Non-surgical Lateral Release in Patellofemoral Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the use of botulinum toxin A injected into
      the lateral thigh muscle improves knee function and reduces knee pain secondary to
      patellofemoral syndrome. The study hypothesis is that botulinum toxin + specific exercises
      will be superior to specific exercises alone in improving knee function and reducing knee
      pain in individuals with patellofemoral syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patellofemoral pain syndrome is a leading cause of knee pain in persons under 45 and is
      particularly common in women. The prevailing theory for the etiology of patellofemoral pain
      is an imbalance in force or timing of the pull of the knee extensor muscles on the patella
      resulting in improper tracking of the patella in the femoral grove. Specifically, the vastus
      medialis is thought to be ineffective in overcoming the lateral pull of the vastus lateralis.
      When exercises designed to focus on improving strength and timing of activation of the vastus
      medialis fail, surgical release of part of the attachment of the vastus lateralis to the
      patella is considered.

      Botulinum toxin temporarily blocks acetylcholine release from motor neurons and is used
      clinically to produce muscle relaxation.

      Subjects with patellofemoral syndrome will be recruited into the study. Half of the subjects
      will be given a placebo injection while the other half will be given an injection of Botox
      (Botulinum Toxin A, Allergen) into the vastus lateralis muscle. Group assignment will be
      randomized and a double blind protocol used. Prior to injection, the subject will record
      their level of knee pain, fill out several knee function questionnaires, and have the
      strength and endurance of their knee extensor muscles tested. All subjects will be given an
      exercise program designed to target strengthening of the medial thigh muscles as well as
      stretching of lateral structures.

      At 4, 6 and 12 weeks knee pain and knee function will again be assessed.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient recruitment in a reasonable time + expiration of study medication
  </why_stopped>
  <start_date>May 2005</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Scale Pain Ratings (VAS)</measure>
    <time_frame>4, 6, 12 weeks</time_frame>
    <description>Visual Analog Scale pain rating (VAS). 10 cm line with anchors at 0 (no pain) and 10 cm (worst imaginable pain). Scores are in cm (0 - 10) 0 no pain, higher values greater pain. Results given are for change at 12 weeks compared to baseline (week 12 score - baseline score)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Anterior Knee Pain Scale.</measure>
    <time_frame>4, 6, 12 weeks</time_frame>
    <description>Anterior Knee Pain Scale: a 13-item questionnaire; a TOTAL score of 0 = severe disability; a score of 100 = no pain or disability. (items are scored 0-5 or 0-10).
Change scores at 12 wks are reported. Inverted so positive values reflect improvement.
Included items: difficulty with: weight bearing, walking, stairs, squat, run, jump, prolonged sitting; presence of limp, swelling, patellar subluxation, atrophy of thigh, reduced knee flexion. Reference: Kujala et al: Scoring of Patellofemoral Disorders. J Arthroscopic Rel Surg, 9(2)159-163, 1993</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional Index Questionnaire</measure>
    <time_frame>4, 6, 12 weeks</time_frame>
    <description>The Functional Index Questionnaire (FIQ) is a self report functional rating scale. Individuals rate eight-activities. Each activity is rated from 0 - 2 with ) being unable to perform the activity and 2 being able to perform the activity without difficulty. The total score is summed for a final score of 0 - 16. 0 indicates that the individual is ubable to perform any of the tasks, 16 indicates that the subject is able to perform all tasks without difficulty. The eight items include: walking (1 block and 1 mile), climbing stairs (2 flights and 4 flights), squatting, kneeling, prolonged sitting, and running</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lower Extremity Functional Scale</measure>
    <time_frame>4, 6, 12 weeks</time_frame>
    <description>The lower extremity functional scale (LEFS) is a self report questionnaire. Subjects rate 19 items related to general activities that require the lower extremities on a scale of 0 - 4. 0 = extreme difficulty or unable to perform the activity, 4 = No difficulty performing the activity. The total of all rankings are summed and divided by the maximum score (76). The score is reported as a percentage. 100% = no difficulty in performing any of the tasks. 0% = extreme difficulty or unable to perform all of the tasks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximal Knee Extensor Force During Concentric and Isometric Contractions</measure>
    <time_frame>4, 6, 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee Extensor Fatigue</measure>
    <time_frame>4, 6, 12 weeks</time_frame>
    <description>This is not available due to data collection errors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle Activation During Maximal Contractions and Fatigue Contractions</measure>
    <time_frame>4, 6, 12 weeks</time_frame>
    <description>muscle activation as EMG ratios of VMO/VL at 30 degrees maximal isometric contraction at 30degrees</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Patellofemoral Pain Syndrome</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of Botulinum toxin A into vastus lateralis of study limb plus exercise program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo injection + exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum toxin A + exercise</intervention_name>
    <description>Injection of 100 units Botox (Botulinum toxin type A) into the Vastus Lateralis of the study leg + 12 weeks of exercise for patellofemoral pain</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Botox</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Injection of 2 cc placebo containing 0.1cc sodium bicarbonate 8.4% (1meq/cc), 0.9cc normal saline and 1 cc of lidocaine into the vastus lateralis of the study leg followed by 12 weeks of exercise for patellofemoral pain syndrome</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  retropatellar knee pain

          -  pain with two of: prolonged sitting, climbing stairs, squatting, running, kneeling,
             hopping, jumping

          -  pain with patellar palpation

          -  symptoms minimum 1 month

          -  Visual Analog Scale for pain (VAS) usual pain 4 of 10 on VAS [0-10 scale, anchors 0 =
             no pain, 10 = worst pain imaginable]

        Exclusion Criteria:

          -  history knee surgery

          -  history patellar dislocation

          -  clinical evidence of meniscal lesion, ligamentous instability, traction apophysitis
             around the patellofemoral complex, patellar tendon pathology, chondral damage,
             osteoarthrosis, spinal referred pain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sheryl D Finucane, PhD, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Physical Therapy, Virginia Commonwealth University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Singer BJ, Silbert PL, Dunne JW, Song S, Singer KP. An open label pilot investigation of the efficacy of Botulinum toxin type A [Dysport] injection in the rehabilitation of chronic anterior knee pain. Disabil Rehabil. 2006 Jun 15;28(11):707-13.</citation>
    <PMID>16809213</PMID>
  </reference>
  <reference>
    <citation>Crossley K, Bennell K, Green S, McConnell J. A systematic review of physical interventions for patellofemoral pain syndrome. Clin J Sport Med. 2001 Apr;11(2):103-10. Review.</citation>
    <PMID>11403109</PMID>
  </reference>
  <reference>
    <citation>Crossley KM, Bennell KL, Cowan SM, Green S. Analysis of outcome measures for persons with patellofemoral pain: which are reliable and valid? Arch Phys Med Rehabil. 2004 May;85(5):815-22.</citation>
    <PMID>15129407</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2007</study_first_submitted>
  <study_first_submitted_qc>July 5, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2007</study_first_posted>
  <results_first_submitted>March 14, 2011</results_first_submitted>
  <results_first_submitted_qc>April 22, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 18, 2011</results_first_posted>
  <last_update_submitted>September 20, 2017</last_update_submitted>
  <last_update_submitted_qc>September 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Botulinum toxin type A</keyword>
  <keyword>Patellofemoral pain syndrome</keyword>
  <keyword>Knee Injuries</keyword>
  <keyword>Exercise Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Patellofemoral Pain Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Botulinum Toxin A Injection + Exercise</title>
          <description>Injection of Botulinum toxin A into vastus lateralis of study limb plus exercise program</description>
        </group>
        <group group_id="P2">
          <title>Placebo Injection + Exercise</title>
          <description>Placebo injection into Vastus Lateralis + exercise</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Botulinum Toxin A Injection + Exercise</title>
          <description>Injection of Botulinum toxin A into vastus lateralis of study limb plus exercise program</description>
        </group>
        <group group_id="B2">
          <title>Placebo Injection + Exercise</title>
          <description>Placebo injection into Vastus Lateralis + exercise</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1"/>
            <count group_id="B2" value="4"/>
            <count group_id="B3" value="5"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="25.5" spread="2.53"/>
                    <measurement group_id="B3" value="27.0" spread="2.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Analog Scale Pain Ratings (VAS)</title>
        <description>Visual Analog Scale pain rating (VAS). 10 cm line with anchors at 0 (no pain) and 10 cm (worst imaginable pain). Scores are in cm (0 - 10) 0 no pain, higher values greater pain. Results given are for change at 12 weeks compared to baseline (week 12 score - baseline score)</description>
        <time_frame>4, 6, 12 weeks</time_frame>
        <population>analysis per protocol. Drop out not included in analysis. mean reduction in Visual Analog Scale for Pain (VAS) from start to 12 weeks.</population>
        <group_list>
          <group group_id="O1">
            <title>Botulinum Toxin A Injection + Exercise</title>
            <description>Injection of Botulinum toxin A into vastus lateralis of study limb plus exercise program</description>
          </group>
          <group group_id="O2">
            <title>Placebo Injection + Exercise</title>
            <description>Placebo injection into Vastus Lateralis + exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale Pain Ratings (VAS)</title>
          <description>Visual Analog Scale pain rating (VAS). 10 cm line with anchors at 0 (no pain) and 10 cm (worst imaginable pain). Scores are in cm (0 - 10) 0 no pain, higher values greater pain. Results given are for change at 12 weeks compared to baseline (week 12 score - baseline score)</description>
          <population>analysis per protocol. Drop out not included in analysis. mean reduction in Visual Analog Scale for Pain (VAS) from start to 12 weeks.</population>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3.7" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Anterior Knee Pain Scale.</title>
        <description>Anterior Knee Pain Scale: a 13-item questionnaire; a TOTAL score of 0 = severe disability; a score of 100 = no pain or disability. (items are scored 0-5 or 0-10).
Change scores at 12 wks are reported. Inverted so positive values reflect improvement.
Included items: difficulty with: weight bearing, walking, stairs, squat, run, jump, prolonged sitting; presence of limp, swelling, patellar subluxation, atrophy of thigh, reduced knee flexion. Reference: Kujala et al: Scoring of Patellofemoral Disorders. J Arthroscopic Rel Surg, 9(2)159-163, 1993</description>
        <time_frame>4, 6, 12 weeks</time_frame>
        <population>The Anterior Knee Pain Scale is a 13-item questionnaire; a score of 0 = severe disability; a score of 100 = no pain or disability. Change scores are reported. Positive values = improvement in symptoms.</population>
        <group_list>
          <group group_id="O1">
            <title>Botulinum Toxin A Injection + Exercise</title>
            <description>Injection of Botulinum toxin A into vastus lateralis of study limb plus exercise program</description>
          </group>
          <group group_id="O2">
            <title>Placebo Injection + Exercise</title>
            <description>Placebo injection into Vastus Lateralis + exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Anterior Knee Pain Scale.</title>
          <description>Anterior Knee Pain Scale: a 13-item questionnaire; a TOTAL score of 0 = severe disability; a score of 100 = no pain or disability. (items are scored 0-5 or 0-10).
Change scores at 12 wks are reported. Inverted so positive values reflect improvement.
Included items: difficulty with: weight bearing, walking, stairs, squat, run, jump, prolonged sitting; presence of limp, swelling, patellar subluxation, atrophy of thigh, reduced knee flexion. Reference: Kujala et al: Scoring of Patellofemoral Disorders. J Arthroscopic Rel Surg, 9(2)159-163, 1993</description>
          <population>The Anterior Knee Pain Scale is a 13-item questionnaire; a score of 0 = severe disability; a score of 100 = no pain or disability. Change scores are reported. Positive values = improvement in symptoms.</population>
          <units>Units on Scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="16.7" spread="4.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Functional Index Questionnaire</title>
        <description>The Functional Index Questionnaire (FIQ) is a self report functional rating scale. Individuals rate eight-activities. Each activity is rated from 0 - 2 with ) being unable to perform the activity and 2 being able to perform the activity without difficulty. The total score is summed for a final score of 0 - 16. 0 indicates that the individual is ubable to perform any of the tasks, 16 indicates that the subject is able to perform all tasks without difficulty. The eight items include: walking (1 block and 1 mile), climbing stairs (2 flights and 4 flights), squatting, kneeling, prolonged sitting, and running</description>
        <time_frame>4, 6, 12 weeks</time_frame>
        <population>No statistical analysis due to small number of subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Botulinum Toxin A Injection + Exercise</title>
            <description>Injection of Botulinum toxin A into vastus lateralis of study limb plus exercise program</description>
          </group>
          <group group_id="O2">
            <title>Placebo Injection + Exercise</title>
            <description>Placebo injection into Vastus Lateralis + exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Functional Index Questionnaire</title>
          <description>The Functional Index Questionnaire (FIQ) is a self report functional rating scale. Individuals rate eight-activities. Each activity is rated from 0 - 2 with ) being unable to perform the activity and 2 being able to perform the activity without difficulty. The total score is summed for a final score of 0 - 16. 0 indicates that the individual is ubable to perform any of the tasks, 16 indicates that the subject is able to perform all tasks without difficulty. The eight items include: walking (1 block and 1 mile), climbing stairs (2 flights and 4 flights), squatting, kneeling, prolonged sitting, and running</description>
          <population>No statistical analysis due to small number of subjects</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11">only one subject</measurement>
                    <measurement group_id="O2" value="10" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post 4 wk</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12">only one subject</measurement>
                    <measurement group_id="O2" value="10" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post 6 wk</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11">only one subject</measurement>
                    <measurement group_id="O2" value="10.7" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post 12 wk</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13">only one subject</measurement>
                    <measurement group_id="O2" value="14" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lower Extremity Functional Scale</title>
        <description>The lower extremity functional scale (LEFS) is a self report questionnaire. Subjects rate 19 items related to general activities that require the lower extremities on a scale of 0 - 4. 0 = extreme difficulty or unable to perform the activity, 4 = No difficulty performing the activity. The total of all rankings are summed and divided by the maximum score (76). The score is reported as a percentage. 100% = no difficulty in performing any of the tasks. 0% = extreme difficulty or unable to perform all of the tasks.</description>
        <time_frame>4, 6, 12 weeks</time_frame>
        <population>No statistical analysis due to small number of subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Botulinum Toxin A Injection + Exercise</title>
            <description>Subjects in this group received an Injection of Botulinum toxin A in the vastus lateralis of the study limb plus exercise program
Subjects received a single injection of 100 ml of Botulinum toxin A (Botulinum toxin type A) into the vastus lateralis muscle of the involved limb near the motor point followed by instruction in a home exercise program for knee and hip musculature that Exercises were performed for 12 weeks, with the number or repetitions and sets determined and progressed by a physical therapist based on reports of knee pain.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Injection + Exercise</title>
            <description>Placebo injection + exercise
Placebo: Injection of 2 cc placebo containing 0.1cc sodium bicarbonate 8.4% (1meq/cc), 0.9cc normal saline and 1 cc of lidocaine into the vastus lateralis of the study leg followed by 12 weeks of exercise for patellofemoral pain syndrome focusing on the knee &amp; hip.</description>
          </group>
        </group_list>
        <measure>
          <title>Lower Extremity Functional Scale</title>
          <description>The lower extremity functional scale (LEFS) is a self report questionnaire. Subjects rate 19 items related to general activities that require the lower extremities on a scale of 0 - 4. 0 = extreme difficulty or unable to perform the activity, 4 = No difficulty performing the activity. The total of all rankings are summed and divided by the maximum score (76). The score is reported as a percentage. 100% = no difficulty in performing any of the tasks. 0% = extreme difficulty or unable to perform all of the tasks.</description>
          <population>No statistical analysis due to small number of subjects</population>
          <units>percentage of total possible score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69">only one subject</measurement>
                    <measurement group_id="O2" value="66.7" spread="14.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post 4 wks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87">only one subject</measurement>
                    <measurement group_id="O2" value="71" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post 6 wks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87">only one subject</measurement>
                    <measurement group_id="O2" value="73" spread="11.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post 12 wks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91">only one subject</measurement>
                    <measurement group_id="O2" value="75" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximal Knee Extensor Force During Concentric and Isometric Contractions</title>
        <time_frame>4, 6, 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Botulinum Toxin A Injection + Exercise</title>
            <description>Injection of Botulinum toxin A into vastus lateralis of study limb plus exercise program</description>
          </group>
          <group group_id="O2">
            <title>Placebo Injection + Exercise</title>
            <description>Placebo injection into Vastus Lateralis + exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Maximal Knee Extensor Force During Concentric and Isometric Contractions</title>
          <units>Nm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Isometric Torque 30deg pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26">only one subject</measurement>
                    <measurement group_id="O2" value="31.3" spread="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Isometric Torque 30deg 4w</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57">only one subject</measurement>
                    <measurement group_id="O2" value="43.7" spread="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Isometric Torque 30deg 6w</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43">only one subject</measurement>
                    <measurement group_id="O2" value="39.0" spread="2.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Isometric Torque 30deg 12w</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37">only one subject</measurement>
                    <measurement group_id="O2" value="42.3" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Knee Extensor Fatigue</title>
        <description>This is not available due to data collection errors</description>
        <time_frame>4, 6, 12 weeks</time_frame>
        <population>This is not available due to data collection errors</population>
        <group_list>
          <group group_id="O1">
            <title>Botulinum Toxin A Injection + Exercise</title>
            <description>Injection of Botulinum toxin A into vastus lateralis of study limb plus exercise program</description>
          </group>
          <group group_id="O2">
            <title>Placebo Injection + Exercise</title>
            <description>Placebo injection into Vastus Lateralis + exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Knee Extensor Fatigue</title>
          <description>This is not available due to data collection errors</description>
          <population>This is not available due to data collection errors</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Muscle Activation During Maximal Contractions and Fatigue Contractions</title>
        <description>muscle activation as EMG ratios of VMO/VL at 30 degrees maximal isometric contraction at 30degrees</description>
        <time_frame>4, 6, 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Botulinum Toxin A Injection + Exercise</title>
            <description>Injection of Botulinum toxin A into vastus lateralis of study limb plus exercise program</description>
          </group>
          <group group_id="O2">
            <title>Placebo Injection + Exercise</title>
            <description>Placebo injection into Vastus Lateralis + exercise</description>
          </group>
        </group_list>
        <measure>
          <title>Muscle Activation During Maximal Contractions and Fatigue Contractions</title>
          <description>muscle activation as EMG ratios of VMO/VL at 30 degrees maximal isometric contraction at 30degrees</description>
          <units>ratio VMO EMG to VL EMG</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>EMG ratio VMO/VL pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.91">Only one subject</measurement>
                    <measurement group_id="O2" value="0.6" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EMG ratio VMO/VL 4wk</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Equipment error during data collection session resulted in invalid data</measurement>
                    <measurement group_id="O2" value="0.61" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EMG ratio VMO/VL 6wk</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.54">Only one subject</measurement>
                    <measurement group_id="O2" value="0.50" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EMG ratio VMO/VL 12wk</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.55">Only one subject</measurement>
                    <measurement group_id="O2" value="0.69" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Botulinum Toxin A Injection + Exercise</title>
          <description>Injection of Botulinum toxin A into vastus lateralis of study limb plus exercise program</description>
        </group>
        <group group_id="E2">
          <title>Placebo Injection + Exercise</title>
          <description>Placebo injection into Vastus Lateralis + exercise</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Early termination due to small number of subjects. No statistical analysis of data due to small number of subjects.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Sheryl Finucane</name_or_title>
      <organization>Virginia Commonwealth University</organization>
      <phone>804-628-3639</phone>
      <email>sfinucan@vcu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

